We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
In October 2001 the Home Secretary asked the Advisory Council on the Misuse of Drugs to review the classification of cannabis preparations in…
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
This publication is an inquiry carried out by the Advisory Council on the Misuse of Drugs.
This report provides an updated harms assessment of gamma-hydroxybutyric acid (GHB) and related substances.
Further advice about the prescribing of controlled drugs by therapeutic radiographers.
This report gives a summary of the main issues the ACMD considered between April 2009 - March 2010.
ACMD annual report 2010 to 2011 Date: Thu Oct 13 10:15:17 BST 2011 Full Document ACMD Annual Report 2010/11 (PDF file - 302kb)
Provides a summary of the main issues the ACMD considered between January 2017 and December 2019.
The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of diphenidine and other related substances.
Letter to the chair of the ACMD inviting them to establish a working group to respond to the recent white paper on drug possession.
These are the agreed terms of reference for the Advisory Council on the Misuse of Drugs.
The Home Office is looking for 16 new members to join the Advisory Council on the Misuse of Drugs (ACMD).
Letter from the Advisory Council on the Misuse of Drugs (ACMD) on young people’s drug use.
Letter from the ACMD recommending a temporary class drug order for U-47,700, etizolam and other designer benzodiazepines.
The second and concluding report on opioid substitution therapy from the Advisory Council on the Misuse of Drugs (ACMD).
Government response to the ACMD review of the evidence on the use and harms of diphenidine.
The Advisory Council on the Misuse of Drugs response to the consultation by NICE on the draft scope of their guidance on cannabis-based products for medicinal use.
Minister for Vulnerability, Safeguarding and Countering Extremism Sarah Newton today (14 December) announced Dr Owen Bowden-Jones as the new chair of the ACMD.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.